Data from Phase 3b ENSURE-AF Study Investigating Once-Daily LIXIANA®▼ (edoxaban)in Patients with Atrial Fibrillation Und

1) Lip, GY. A prospective evaluation of edoxaban compared to warfarin in subjects
undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS
UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study. Am Heart J. 2015
May;169(5):597-604.
2) Giugliano R, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N
Engl J Med. 2013;369(22):2093-2104.
3) Kirchhof P, et al. Management of atrial fibrillation in seven European countries after
the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of
the PREvention oF thromboembolic events - European Registry in Atrial Fibrillation
(PREFER in AF). Europace. 2013. doi: 10.1093/europace/eut263.   
4) Prolongation PREFER in AF Registry. European Multinational Prolongation Registry on
Prevention of Thromboembolic Events in Atrial Fibrillation. DSE-EAF-01-13. Data on
file.
5) Agnelli G, et al. The management of acute venous thromboembolism in clinical practice
- study rationale and protocol of the European PREFER in VTE Registry. Thromb J. 2015
doi: 10.1186/s12959-015-0071.
6) National Heart, Lung and Blood Institute - What is Atrial Fibrillation. Available at:
http://www.nhlbi.nih.gov/health/dci/Dise... . [Last
accessed: March 2016].
7) Iqbal MB, et al. Recent developments in atrial fibrillation. BMJ. 2005;330(7485)
:238-43.
8) Krijthe BP, et al. Projections on the number of individuals with atrial fibrillation
in the European Union, from 2000 to 2060. Eur Heart J. 2013;34(35):2746-2751.
9) Camm A, et al. Guidelines for the management of atrial fibrillation: The Task Force
for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
Eur Heart J. 2010;31(19):2369-2429.
10) Ball J, et al. Atrial fibrillation: Profile and burden of an evolving epidemic in the
21st century. Int J Card. 2013;167:1807-1824.
11) Deep Vein Thrombosis (DVT) / Pulmonary Embolism (PE) - Blood Clot Forming in a Vein.
Centers for Disease Control and Prevention. Available at:
http://www.cdc.gov/ncbddd/dvt/facts.html... . [Last accessed: March 2016].
12) Van Beek E, et al. Deep vein thrombosis and pulmonary embolism. New York: John Wiley &
Sons, 2009. Print.
13) Cohen A, et al. Venous thromboembolism (VTE) in Europe. Thromb Haemost. 2007;98(4)
:756-764.
14) Kearon C. Natural history of venous thromboembolism. Circulation. 2003;107(23 suppl 1)
:I-22-30.

August 2016 EDX/16/0186

 
Contact 
Lydia Worms (Europe) 
Daiichi Sankyo Europe GmbH 
Edoxaban Communications & Product PR Europe 
+49(89)7808751